| Literature DB >> 35336012 |
Evangelia Christou1, John R Pearson1, Ana M Beltrán2, Yilian Fernández-Afonso3, Lucía Gutiérrez3,4, Jesús M de la Fuente3,4, Francisco Gámez5, María L García-Martín1,4, Carlos Caro1.
Abstract
The development of nanoplatforms prepared to perform both multimodal imaging and combined therapies in a single entity is a fast-growing field. These systems are able to improve diagnostic accuracy and therapy success. Multicomponent Nanoparticles (MCNPs), composed of iron oxide and gold, offer new opportunities for Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) diagnosis, as well as combined therapies based on Magnetic Hyperthermia (MH) and Photothermal Therapy (PT). In this work, we describe a new seed-assisted method for the synthesis of Au@Fe Nanoparticles (NPs) with a flower-like structure. For biomedical purposes, Au@Fe NPs were functionalized with a PEGylated ligand, leading to high colloidal stability. Moreover, the as-obtained Au@Fe-PEG NPs exhibited excellent features as both MRI and CT Contrast Agents (CAs), with high r2 relaxivity (60.5 mM-1⋅s-1) and X-ray attenuation properties (8.8 HU mM-1⋅HU). In addition, these nanoflowers presented considerable energy-to-heat conversion under both Alternating Magnetic Fields (AMFs) (∆T ≈ 2.5 °C) and Near-Infrared (NIR) light (∆T ≈ 17 °C). Finally, Au@Fe-PEG NPs exhibited very low cytotoxicity, confirming their potential for theranostics applications.Entities:
Keywords: CT; MRI; gold–iron nanoparticles; magnetic hyperthermia; multimodal imaging; nanoflowers; photothermal therapy
Year: 2022 PMID: 35336012 PMCID: PMC8955043 DOI: 10.3390/pharmaceutics14030636
Source DB: PubMed Journal: Pharmaceutics ISSN: 1999-4923 Impact factor: 6.321
Figure 1(a) Representative TEM (left) and STEM (right) images of Au@Fe NPs. The inset represents a scheme of the obtained NPs. Scale bar corresponds to 50 nm. (b) Spatial distribution of metal atoms in the Au@Fe NPs as measured by HAADF and EDX. Scale bar corresponds to 10 nm. (c) Size distribution derived from counting at least 100 NPs in TEM images of Au seeds (red) and Au@Fe NPs (gray). (d) X-ray powder diffraction (XRD) pattern of Au@Fe NPs.
Figure 2(a) UV–Vis–NIR spectrum of Au@Fe NPs. (b) FTIR spectra of oleic acid capped Fe@Au NPs (black), PEGylated ligand (gray), and PEGylated Fe@Au NPs (blue). (c) Hydrodynamic diameters in saline of Au@Fe-PEG NPs. (d) Stability measured over time.
Figure 3(a) Hysteresis loop of Au@Fe-PEG NPs measured at 300 K scaled to the maximum magnetization value. (b) Plot of relaxation rate (1/T2) vs. the concentration of Fe in the Au@Fe-PEG NP suspension determined at 1.44 T (black dots) and 9.4 T (blue dots), and the linear fits (black and blue lines) whose slopes correspond to the transverse relaxivities (r2) of Au@Fe-PEG NPs at both magnetic fields. (c) X-ray attenuation measured as the linear relationship between the normalized ∆HU of the CT images and the Au concentration of the Au@Fe-PEG NP solutions. (d) Thermal stability test of Au@Fe-PEG NPs measured under NIR irradiation (blue) and AMF (black). The dashed red line is a fit to the solution of the Fourier transform of a point-like source.
Figure 4Representative optical microscopy images of HFF-1 cells incubated with Au@Fe-PEG NPs: (a) negative control, (b) positive control, (c) cells incubated with 50 µg/mL Fe + Au. Images show a merge of brightfield (gray), Hoechst 33342 (blue), and PI (red). Scale bars correspond to 100 µm. Quantification of total number of cells per well, (d) percentage of dead cells, (e) mitochondrial activity (f) of cells exposed to increasing concentration of Au@Fe-PEG NPs.